Literature DB >> 10817749

Single-oral-dose azithromycin prophylaxis against experimental streptococcal or staphylococcal aortic valve endocarditis.

A Tsitsika1, A Pefanis, G S Perdikaris, I Donta, P Karayiannakos, H Giamarellou.   

Abstract

Azithromycin and ampicillin protected 94 and 72% of animals challenged with Streptococcus oralis, respectively (P = 0.177), while azithromycin and vancomycin protected 59 and 94% of the methicillin-resistant Staphylococcus aureus (MRSA)-challenged animals, respectively (P = 0.018). Azithromycin is effective in preventing experimental streptococcal endocarditis, but against MRSA it is less effective than vancomycin.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10817749      PMCID： PMC89953          DOI： 10.1128/AAC.44.6.1754-1756.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

Review 1.  Staphylococcus aureus infections.

Authors:  F D Lowy
Journal:  N Engl J Med       Date:  1998-08-20       Impact factor: 91.245

2.  Successful prophylaxis of experimental streptococcal endocarditis with single-dose amoxicillin administered after bacterial challenge.

Authors:  P Berney; P Francioli
Journal:  J Infect Dis       Date:  1990-02       Impact factor: 5.226

Review 3.  Prevention of infective endocarditis.

Authors:  D T Durack
Journal:  N Engl J Med       Date:  1995-01-05       Impact factor: 91.245

4.  A microtechnique for the determination of antibiotics in muscle.

Authors:  O Cars; S Ogren
Journal:  J Antimicrob Chemother       Date:  1981-07       Impact factor: 5.790

5.  The comparative activity of azithromycin, macrolides and amoxycillin against streptococci in experimental infections.

Authors:  A E Girard; C R Cimochowski; J A Faiella
Journal:  J Antimicrob Chemother       Date:  1993-06       Impact factor: 5.790

6.  Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis.

Authors:  J T Van der Meer; W Van Wijk; J Thompson; J P Vandenbroucke; H A Valkenburg; M F Michel
Journal:  Lancet       Date:  1992-01-18       Impact factor: 79.321

7.  Mechanisms of successful amoxicillin prophylaxis of experimental endocarditis due to Streptococcus intermedius.

Authors:  P Moreillon; P Francioli; D Overholser; P Meylan; M P Glauser
Journal:  J Infect Dis       Date:  1986-11       Impact factor: 5.226

8.  Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution.

Authors:  A E Girard; D Girard; A R English; T D Gootz; C R Cimochowski; J A Faiella; S L Haskell; J A Retsema
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

9.  Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides.

Authors:  D J Hardy; D M Hensey; J M Beyer; C Vojtko; E J McDonald; P B Fernandes
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

10.  Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart.

Authors:  B B Perlman; L R Freedman
Journal:  Yale J Biol Med       Date:  1971-10
View more
  1 in total

Review 1.  Antibacterials for the prophylaxis and treatment of bacterial endocarditis in children.

Authors:  B Capitano; R Quintiliani; C H Nightingale; D P Nicolau
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.